title: Major histocompatibility complex class I to III allotypes in patients with AIDS-related complex/Walter-Reed 5, disseminated Kaposi's sarcoma and in normal controls. The ARC-IVIG Study Group.
abstract: In HIV-infected patients major histocompatibility complex (MHC) class I and II (= HLA-A, B, C, DR) association has been controversial. Of the MHC class III coded complement components C2, BF, C4A/C4B especially C4 allotypes appear of major immunogenetic relevance for their potential differences in virus neutralizing potency and immune complex formation. In the present study 29 patients with AIDS-related complex and Walter-Reed 5 ARC/WR5), 35 patients with disseminated Kaposi's sarcoma (KS), and 160 HIV-negative control individuals were compared for MHC class I to III allotypes. Diagnosis of ARC and KS (WR criteria) was done by clinical and laboratory parameters, MHC testing, by standard procedures. An increase in frequency (p less than or equal to 0.05) was observed between ARC/WR5 patients and controls for HLA-B35/CW4, DRW14, a decrease for B16, CW6/DR7. However, values were not significant if corrected for the number of tested antigens. No significant differences were seen between KS and ARC patients or controls for class III allotypes, nor for previously reported associations, e.g. for B8, DR2, DR3, and especially DR5, including the DR5 splits DRW11, 12. The results indicate the lack of a strong MHC association with the investigated antigens in West German Caucasoids, and support the hypothesis of ethnic dependence of HIV-related diseases. The HLA-B35/CW4 increase, also associated with the duplicated C4 A*3 A*2 and the silent C4B*Q0, was more pronounced in ARC patients with progression to AIDS-OI. The increased frequency of C4B*Q0 alleles in these patients was thought to be secondary to a hypothetical increase in 'converted' and dysregulated C4 genes not seen to be associated in this study.
authors.affiliation: Institut für Medizinische Mikrobiologie und Hygiene, Universität Köln, BRD.
authors.forename: G
authors.initials: G
authors.lastname: Plum
authors.forename: E
authors.initials: E
authors.lastname: Siebel
authors.forename: C
authors.initials: C
authors.lastname: Bendick
authors.forename: H
authors.initials: H
authors.lastname: Rasokat
authors.forename: M
authors.initials: M
authors.lastname: Braun
authors.forename: H
authors.initials: H
authors.lastname: Krickeberg
authors.forename: G
authors.initials: G
authors.lastname: Mauff
mesh_terms: D000386:AIDS-Related Complex / Q000235:genetics / Q000276:immunology* / Q000628:therapy; D006680:HLA Antigens / Q000032:analysis* / Q000235:genetics / Q000276:immunology; D006801:Humans; D007116:Immunization, Passive; D007126:Immunoglobulin Allotypes / Q000032:analysis* / Q000235:genetics / Q000276:immunology; D008285:Major Histocompatibility Complex / Q000235:genetics / Q000276:immunology*; D010641:Phenotype; D011379:Prognosis; D012514:Sarcoma, Kaposi / Q000235:genetics / Q000276:immunology* / Q000628:therapy
chemical_list: D006680:HLA Antigens; D007126:Immunoglobulin Allotypes